Anne Katz, PhD, RN, FAAN
Aug 26, 2016 1:08 PM
Scalp cooling has been shown to be somewhat effective in preventing chemotherapy-related alopecia. What do you recommend to your patients, especially women with breast cancer? Does your infusion center or chemotherapy unit allow or promote this? How many patients use this and what are the patient...
Mark R. Hutchins, MD
Apr 26, 2016 10:50 PM
Has there ever been a PRCT of AC/T vs "other" in a pure TNBC stratified group (in the NeoAdj setting or the Adj setting?) showing that AC/T vs "other" showed a superior survival? When we say that AC/T shows a survival advantage, advantage over what?
The origninal AC vs CMF showed little if any...
Arsh Singh, MD
Jan 18, 2016 1:00 PM
In a 33 y/o caucasian woman with T2N0 Her 2 Positive invasive ductal carcinoma (both by IHC and FISH), ER 50% and PR negative, is it okay to use AC followed by T along with herceptin and pertuzumab in the neoadjuvant setting?
Adverse Event Management in Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer Christian Rolfo, Ignacio Gil-Bazo, Solange Peters
Oct 15, 2015 5:23 PM
Joseph Kim, MD, MPH, MBA
Oct 09, 2015 8:57 AM
This article in JAMA titled, "Facilitating Quality Improvement - Pushing the Pendulum Back Toward Process Measures" caught my attention the other day. The author starts by reflecting on the ongoing debate: should we focus more...